Translational attenuation differentially alters the fate of disease-associated fibulin proteins
Related Experiment Video
Updated: May 19, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
John D Hulleman1, William E Balch, Jeffery W Kelly
1Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, USA. hulleman@scripps.edu
Abstract:
Mutations in fibulin proteins that cause cellular secretion deficiencies are linked to a variety of diseases, ranging from retinopathies to cutis laxa (CL). One secretion-deficient fibulin mutant, R345W fibulin-3, causes the macular dystrophy malattia leventinese by increased endoplasmic reticulum retention and/or extracellular misfolding. Herein, we report that small-molecule activation of the PERK arm of the unfolded protein response partially rescues R345W secretion deficiencies through translational attenuation mediated by eIF2α phosphorylation. Enhanced mutant fibulin-3 secretion can also be achieved by activation of a PERK-independent eIF2α kinase through arsenite treatment and is independent of activating transcription factor 4 signaling and protein translation. However, this translational attenuation strategy was unsuccessful for enhancing the secretion deficiencies of fibulin-5 mutants associated with age-related macular degeneration or CL. While lowered growth temperature enhanced the secretion of mutants associated with CL (C217R and S227P), these effects were not mediated through translational attenuation. In stark contrast to the situation with fibulin-3, protein translation was required for efficient wild-type and mutant fibulin-5 secretion. These data suggest that alteration of specific cellular signaling pathways and proteostasis network components can differentially influence fibulin fate, a hypothesis that could be exploited as a therapy for fibulin-related diseases.
Insights
Targeting cellular secretion pathways partially rescues fibulin-3 mutations causing malattia leventinese. Strategies like PERK activation show promise, but translational attenuation is ineffective for fibulin-5 secretion defects.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Fibulin mutations causing secretion deficiencies are linked to diseases like retinopathies and cutis laxa (CL).
- The R345W fibulin-3 mutant causes malattia leventinese due to endoplasmic reticulum retention and extracellular misfolding.
Purpose of the Study:
- To investigate therapeutic strategies for fibulin secretion deficiencies by modulating cellular signaling pathways.
- To determine if translational attenuation can rescue fibulin secretion defects.
Main Methods:
- Activation of the PERK arm of the unfolded protein response (UPR).
- Treatment with arsenite to activate a PERK-independent eIF2α kinase.
- Assessment of mutant fibulin secretion under varying conditions (e.g., temperature).
- Analysis of the role of activating transcription factor 4 (ATF4) and protein translation.
Main Results:
- PERK activation partially rescued R345W fibulin-3 secretion via translational attenuation.
- Arsenite treatment also enhanced R345W fibulin-3 secretion independently of ATF4 and protein translation.
- Translational attenuation failed to rescue secretion deficiencies in fibulin-5 mutants.
- Lowered growth temperature improved secretion of CL-associated fibulin mutants, but not via translational attenuation.
- Protein translation was essential for wild-type and mutant fibulin-5 secretion.
Conclusions:
- Cellular signaling pathways and proteostasis network components differentially affect fibulin fate.
- Targeting specific pathways offers a potential therapeutic approach for fibulin-related diseases.
- Strategies effective for fibulin-3 may not be applicable to fibulin-5 due to distinct secretion requirements.
More Related Videos
09:29Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications
Published on: May 18, 2017
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
RNA Splicing
Intracellular Signaling Affects Focal Adhesions
Some...